Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$16.29
+0.40%
Mkt Cap $2.01B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
Implied Upside
-4.8%
Consensus $15.50 vs current $16.29
NASDAQ·Healthcare·Biotechnology
$16.29
+0.40%
Mkt Cap $2.01B
No recent rating data.
Price Target (9 analysts)
$15.50
Range $15.00 – $16.00
-4.8%
Consensus $15.50 vs current $16.29